Journal of Clinical and Aesthetic Dermatology

JUN 2017

An evidence-based, peer-reviewed journal for practicing clinicians in the field of dermatology

Issue link:

Contents of this Issue


Page 30 of 63

31 JCAD journal of clinical and aesthetic dermatology June 2017 • Volume 10 • Number 6 2014;19(3):1–4. 28. Drake L. Survey shows physical d iscomfort with visible signs of rosacea. Rosacea Review 2012. rticle_3.php. Accessed on March 9, 2016. 29. van der Linden MM, van Rappard DC, Daams JG, et al. Health-related quality of life in patients with cutaneous rosacea: a systematic review. Acta Derm Venereol. 2015;95(4):395–400. 30. Drake L. Survey shows rosacea's emotional toll, positive effects of medical therapy. 2007. http://www. php. Accessed on March 9, 2016. 31. Huynh TT. Burden of disease: the psychosocial impact of rosacea on a patient's quality of life. Am Health Drug Benefits. 2013;6(6):348–354. 32. Elewski BE. Results of a national rosacea patient survey: common issues that concern rosacea sufferers. J Drugs Dermatol. 2009;8(2):120–123. 33. Fitzpatrick TB. The validity and p racticality of sun-reactive skin types I through VI. Arch Dermatol. 1988;124(6):869–871. 34. Powell FC. Rosacea. N Engl J Med. 2005;352(8):793–803. 35. Dahl MV, Katz HI, Krueger GG, et al. Topical metronidazole maintains remissions of rosacea. Arch Dermatol. 1998;134(6):679–683. 36. Thiboutot DM, Fleischer AB, Del Rosso JQ, Rich P. A multicenter study of topical azelaic acid 15% gel in combination with oral doxycycline as initial therapy and azelaic acid 15% gel as maintenance monotherapy. J Drugs Dermatol. 2009;8(7):639–648. 37. Johnson SM, LeVine P. Self- reported treatment impressions and satisfaction of papulopustular rosacea patients treated with doxycycline, USP, 40mg capsules. J Drugs Dermatol. 2011;10(12):1376–1381. 38. Ryan CL, Bauman K. Educational attainment in the United States: 2015. 2016. h ttps:// m/Census/library/publications/2016/ demo/p20–578.pdf. Accessed on April 12, 2016. 39. DeNavas-Walt C, Proctor BD, U.S. Census Bureau. Income and Poverty in the United States: 2014. Current Population Reports, P60–252. Washington, DC: U.S. Government Printing Office; 2015. 40. Table H-1. Income limits for each fifth and top 5 percent of all households: 1967 to 2014. 2015. income/data/historical/household/. Accessed on April 12, 2016. 41. Chosidow O, Cribier B. Epidemiology of rosacea: updated data. Ann Dermatol Venereol. 2011;138(Suppl 3):S179–S183. 42. Bohm D, Schwanitz P, Stock GS, et al. Symptom severity and psychological sequelae in rosacea: results of a survey. Psychol Health Med. 2014;19(5):586–591. O R I G I N A L R E S E A R C h

Articles in this issue

Links on this page

Archives of this issue

view archives of Journal of Clinical and Aesthetic Dermatology - JUN 2017